GlaxoSmithKline is set to pay one of the pharmaceutical industry’s largest ever fines after resolving disputes with the US government over the way it marketed and developed its drugs, at a cost of $3bn (£1.8bn).
http://www.telegraph.co.uk/finance/newsbysector/pharmaceuticalsandchemicals/8866885/GlaxoSmithKline-to-settle-drug-disputes-for-3bn.html
No comments:
Post a Comment